Mechanisms of poly (epsilon-caprolactone) lipid-core nanocapsules in melanoma development (2013)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Assunto: NANOTECNOLOGIA
ABNT
DREWES, Carine Cristiane et al. Mechanisms of poly (epsilon-caprolactone) lipid-core nanocapsules in melanoma development. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 13 set. 2024. , 2013APA
Drewes, C. C., Bexiga, C. G., Fiel, L. A., Pohlmann, A., Guterres, S., & Farsky, S. H. P. (2013). Mechanisms of poly (epsilon-caprolactone) lipid-core nanocapsules in melanoma development. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Drewes CC, Bexiga CG, Fiel LA, Pohlmann A, Guterres S, Farsky SHP. Mechanisms of poly (epsilon-caprolactone) lipid-core nanocapsules in melanoma development. Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 69 res. FCF133.[citado 2024 set. 13 ]Vancouver
Drewes CC, Bexiga CG, Fiel LA, Pohlmann A, Guterres S, Farsky SHP. Mechanisms of poly (epsilon-caprolactone) lipid-core nanocapsules in melanoma development. Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 69 res. FCF133.[citado 2024 set. 13 ]